| TEQCX | VGTSX | TEQCX / VGTSX | |
| Total Expense Ratio | 1.92 | 0.17 | 1,129% |
| Annual Report Gross Expense Ratio | 2.23 | 0.17 | 1,312% |
| Fund Existence | 23 years | 30 years | - |
| Gain YTD | 13.510 | 15.630 | 86% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.46B | 666B | 0% |
| Annual Yield % from dividends | 0.44 | 2.40 | 18% |
| Returns for 1 year | 15.10 | 20.21 | 75% |
| Returns for 3 years | 64.27 | 61.28 | 105% |
| Returns for 5 years | 24.41 | 37.12 | 66% |
| Returns for 10 years | 67.82 | 104.51 | 65% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BIPSX | 47.99 | N/A | N/A |
| ProFunds Biotechnology UltraSector Svc | |||
| FKACX | 27.59 | N/A | N/A |
| Franklin Growth Opportunities C | |||
| AMCFX | 45.69 | -0.20 | -0.44% |
| American Funds AMCAP F-2 | |||
| IVVYX | 24.83 | -0.36 | -1.43% |
| Nomura International Core Equity Y | |||
| DRMCX | 6.39 | -0.10 | -1.54% |
| Virtus Silvant Mid-Cap Growth Inst | |||